Federal Register / Vol. 74, No. 103 / Monday, June 1, 2009 / Notices 26243 

Independent Scientific Peer Review 

Panel Report: Updated Validation 

Status of New Versions and 

Applications of the Murine Local Lymph 

Node Assay: A Test Method for 

Assessing the Allergic Contact 

Dermatitis Potential of Chemicals and 

Products (available at http:// 

iccvam.niehs.nih.gov/docs/ 

immunotox_docs/ 

LLNAPRPRept2009.pdf). The revised 

draft documents reviewed by the Panel 

and the draft ICCVAM test method 

recommendations are available at http:// 

iccvam.niehs.nih.gov/methods/ 

immunotox/llna_PeerPanel.htm. 

Request for Public Comments 

NICEATM invites the submission of 

written comments on the Panel’s report. 

When submitting written comments, 

please refer to this Federal Register 

notice and include appropriate contact 

information (name, affiliation, mailing 

address, phone, fax, e-mail, and 

sponsoring organization, if applicable). 

All comments received will be made 

publicly available via the NICEATM– 

ICCVAM Web site at http:// 

iccvam.niehs.nih.gov/methods/ 

immunotox/llna_PeerPanel.htm. In 

addition, there will be an opportunity 

for oral public comments on the Panel’s 

report during an upcoming meeting of 

SACATM scheduled for June 25–26, 

2009 (74 FR 19562). Information 

concerning the SACATM meeting is 

available at http://ntp.niehs.nih.gov/go/ 

7441. ICCVAM will consider the Panel 

report along with SACATM and public 

comments when finalizing test method 

recommendations. An ICCVAM test 

method evaluation report, which will 

include the final ICCVAM 

recommendations, will be forwarded to 

relevant Federal agencies for their 

consideration. The evaluation report 

will also be available to the public on 

the NICEATM–ICCVAM Web site at 

http://iccvam.niehs.nih.gov/methods/ 

immunotox/llna.htm and by request 

from NICEATM (see ADDRESSES above). 

Background Information on ICCVAM, 

NICEATM, and SACATM 

ICCVAM is an interagency committee 

composed of representatives from 15 

Federal regulatory and research agencies 

that use, generate, or disseminate 

toxicological information. ICCVAM 

conducts technical evaluations of new, 

revised, and alternative methods with 

regulatory applicability and promotes 

the scientific validation and regulatory 

acceptance of toxicological test methods 

that more accurately assess the safety 

and hazards of chemicals and products 

and that refine, reduce, and replace 

animal use. The ICCVAM Authorization 

Act of 2000 (42 U.S.C. 285l–3) 

established ICCVAM as a permanent 

interagency committee of the NIEHS 

under NICEATM. NICEATM 

administers ICCVAM and provides 

scientific and operational support for 

ICCVAM-related activities. NICEATM 

and ICCVAM work collaboratively to 

evaluate new and improved test 

methods applicable to the needs of U.S. 

Federal agencies. Additional 

information about ICCVAM and 

NICEATM can be found on their Web 

site (http://iccvam.niehs.nih.gov). 

SACATM was established January 9, 

2002, and is composed of scientists from 

the public and private sectors (67 FR 

11358). SACATM provides advice to the 

Director of the NIEHS, ICCVAM, and 

NICEATM regarding the statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. Additional 

information about SACATM, including 

the charter, roster, and records of past 

meetings, can be found at http:// 

ntp.niehs.nih.gov/ see ‘‘Advisory Board 

& Committees’’ (or directly at http:// 

ntp.niehs.nih.gov/go/167). 

Reference 

ICCVAM. 2003. ICCVAM Guidelines for 

the Nomination and Submission of New, 

Revised, and Alternative Test Methods. NIH 

Publication No. 03–4508. Research Triangle 

Park, NC: NIEHS. Available at: http:// 

iccvam.niehs.nih.gov. 

Dated: May 19, 2009. 

John R. Bucher, 

Associate Director, NTP. 

[FR Doc. E9–12360 Filed 5–29–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; Survey of NHLBI 

Constituents’ Health Information 

Needs and Preferred Formats 

Summary: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Heart, Lung and Blood Institute 

(NHLBI), the National Institutes of 

Health (NIH) has submitted to the Office 

of Management and Budget (OMB) a 

request for review and approval of the 

information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on March 19, 2009, pages 

11736–11737 and allowed 60 days for 

public comment. No public comments 

were received. The purpose of this 

notice is to allow an additional 30 days 

for public comment. The National 

Institutes of Health may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Proposed Collection: Title: Survey of 

NHLBI Constituents’ Health Information 

Needs and Preferred Formats. Type of 

Information Collection Request: NEW. 

Need and Use of Information Collection: 

The purpose of this survey is to obtain 

information from NHLBI constituents 

(health professionals, patients and their 

families, and the general public) for the 

purpose of evaluating their health 

information and education needs and 

format preferences. The Consumer 

Services Team (CST) will use the data 

collected in this survey to create a 3- 

year Strategic Plan. The findings from 

the survey, described in the Strategic 

Plan, will be used to develop new 

health information materials for NHLBI 

constituents and to revise materials 

currently in the Institute’s portfolio. 

Frequency of Response: Once every 3 

years. Affected Public: Individuals. Type 

of Respondents: Individuals who have 

been consumers of NHLBI information 

within the past 3 years. The annual 

reporting burden is as follows: 

Estimated Number of Respondents: 

2,450; Estimated Number of Responses 

per Respondent: 1; Average Burden 

Hours per Response: 0.2; and Estimated 

Total Annual Burden Hours Requested: 

162. The annualized cost to respondents 

is estimated at: $3,518.62. There are no 

Capital Costs, Operating Costs and/or 

Maintenance Costs to report. 

Type of respondents 

Estimated 

number of 

respondents 

Estimated 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Estimated 

total annual 

burden hours 

requested 

General Public ................................................................................................. 1,075 0.33 0.2 71 

Private Companies .......................................................................................... 332 0.33 0.2 22 

26244 Federal Register / Vol. 74, No. 103 / Monday, June 1, 2009 / Notices 

Type of respondents 

Estimated 

number of 

respondents 

Estimated 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Estimated 

total annual 

burden hours 

requested 

Public Sector Groups ....................................................................................... 332 0.33 0.2 22 

Health Professionals ........................................................................................ 711 0.33 0.2 47 

Totals ........................................................................................................ 2,450 ........................ ........................ 162 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact: Dr. Ann 

M. Taubenheim, Principal Investigator, 

National Heart, Lung, and Blood 

Institute, Office of Communications and 

Legislative Activities, NIH, 31 Center 

Drive, Building 31, Room 4A10, 

Bethesda, MD 21045, or call non-tollfree number 301–496–4236 or e-mail 

your request, including your address, to 

taubenha@nhlbi.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: May 22, 2009. 

Ann M. Taubenheim, 

Principal Investigator, NHLBI, National 

Institutes of Health. 

[FR Doc. E9–12604 Filed 5–29–09; 8:45 am] 

BILLING CODE 4140–10–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0220] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Experimental 

Study of Nutrition Symbols on Food 

Packages 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the Experimental Study of Nutrition 

Symbols on Food Packages. 

DATES: Submit written or electronic 

comments on the collection of 

information by July 31, 2009. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

Experimental Study of Nutrition 

Symbols on Food Packages 

FDA has been following the 

emergence of front-of-package nutrition 

symbols in the marketplace. These 

symbols are associated with programs 

from sources including food 

manufacturers, retailers, and third party 

organizations (e.g., trade and health 

organizations). The symbols are 

intended to assist consumer choice by 

providing simplified and easilyaccessible information on the 

nutritional attributes of a food product. 

Relevant and nonproprietary 

information about the effects of 

nutrition symbols on consumers, 

however, is limited (see, for example, 

Feunekes et al., 2008; ‘‘FDA Comments 

on Symbols Public Hearing and Current 

Plans for Addressing Issues,’’ Docket